TrialAmerican journal of clinical dermatology2022

Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics.

John E Jett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.